Ribose-5-phosphate isomerase structure
|
Common Name | Ribose-5-phosphate isomerase | ||
---|---|---|---|---|
CAS Number | 9023-83-0 | Molecular Weight | N/A | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | N/A | Melting Point | N/A | |
MSDS | USA | Flash Point | N/A |
Use of Ribose-5-phosphate isomeraseRibose-5-phosphate isomerase (Phosphoriboisomerase) is a biochemical reagent that can be used as a biological material or organic compound for life science related research. |
Name | d-ribose-5-phosphate ketol-isomerase type i |
---|---|
Synonym | More Synonyms |
Description | Ribose-5-phosphate isomerase (Phosphoriboisomerase) is a biochemical reagent that can be used as a biological material or organic compound for life science related research. |
---|---|
Related Catalog |
Appearance of Characters | partially purified powder |
---|---|
Storage condition | -20°C |
Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |
Initial characterization of the human central proteome.
BMC Syst. Biol. 5 , 17, (2011) On the basis of large proteomics datasets measured from seven human cell lines we consider their intersection as an approximation of the human central proteome, which is the set of proteins ubiquitous... |
|
The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
Genome Res. 14 , 2121-7, (2004) The National Institutes of Health's Mammalian Gene Collection (MGC) project was designed to generate and sequence a publicly accessible cDNA resource containing a complete open reading frame (ORF) for... |
|
Ribose-5-phosphate isomerase deficiency: new inborn error in the pentose phosphate pathway associated with a slowly progressive leukoencephalopathy.
Am. J. Hum. Genet. 74(4) , 745-51, (2004) The present article describes the first patient with a deficiency of ribose-5-phosphate isomerase (RPI) (Enzyme Commission number 5.3.1.6) who presented with leukoencephalopathy and peripheral neuropa... |
MFCD00131900 |